Fairvalue-Calculator Fairvalue-Calculator
EN DE

Y-Biologics, Inc (338840) Fair Value & Analysis

Healthcare · KR · Market cap 203B KRW

Price12,930 KRW
Fair Value5,338 KRW
Upside-58.7%
Quality95/100
Evidence: Low Range 4,003 KRW – 6,672 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Y-Biologics, Inc (338840) currently trades at 12,930 KRW, while our model-based Fair Value estimate is 5,338 KRW — implying the stock looks roughly 58.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor. It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166, AR169, and AR170 for solid cancers; and AR153, a pH-dependent antibody for the treatment of solid cancer. Y-Biologics, Inc. was incorporated in 2007 and is headquartered in Daejeon, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Y-Biologics, Inc (338840) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 5,338 KRW versus a price of 12,930 KRW — about −59% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 338840?
Our 21-model fair value for Y-Biologics, Inc is 5,338 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 12,930 KRW.
What is the quality score of 338840?
Y-Biologics, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.